◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › RDGT

Ridgetech, Inc. (RDGT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Pharmaceutical Retailers · DATA UPDATED 2026-07-09

Ridgetech, Inc. (RDGT) operates in the Pharmaceutical Retailers industry and is headquartered in Hangzhou, China with about 61 employees. Its market capitalization is roughly $1 million. In the fiscal year ended 2025-03-31, RDGT reported $120M in revenue and $10M in net income.

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale.

Interactive charts & full statements → Open the RDGT valuation workbench →

RDGT Revenue & Earnings History — Annual Income Statement

Income statement2025-03-312024-03-312023-03-312022-03-31
Total Revenue$120M$124M$120M$164M
Gross Profit$4M$5M$4M$36M
Operating Income (EBIT)($1M)$1M($13M)($2M)
Net Income$10M($4M)($21M)($3M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDGT Free Cash Flow History

RDGT Balance Sheet History

Balance sheet2025-03-312024-03-312023-03-312022-03-31
Total Assets$64M$95M$91M$106M
Total Liabilities$35M$81M$74M$84M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RDGT viewer.

Other Companies in Pharmaceutical Retailers

← RDDTAll stocksRDI →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.